One-Tube Real-Time Isothermal Amplification Assay To Identify and Distinguish Human Immunodeficiency Virus Type 1 Subtypes A, B, and C and Circulating Recombinant Forms AE and AG

ABSTRACT To halt the human immunodeficiency virus type 1 (HIV-1) epidemic requires interventions that can prevent transmission of numerous HIV-1 subtypes. The most frequently transmitted viruses belong to the subtypes A, B, and C and the circulating recombinant forms (CRFs) AE and AG. A fast one-tube assay that identifies and distinguishes among subtypes A, B, and C and CRFs AE and AG of HIV-1 was developed. The assay amplifies a part of the gag gene sequence of the genome of all currently known HIV-1 subtypes and can identify and distinguish among the targeted subtypes as the reaction proceeds, because of the addition of subtype-specific molecular beacons with multiple fluorophores. The combination of isothermal nucleic acid sequence-based amplification and molecular beacons is a new approach in the design of real-time assays. To obtain a sufficiently specific assay, we developed a new strategy in the design of molecular beacons, purposely introducing mismatches in the molecular beacons. The subtype A and CRF AG isolates reacted with the same molecular beacon. We tested the specificity and sensitivity of the assay on a panel of the culture supernatant of 34 viruses encompassing all HIV-1 subtypes: subtypes A through G, CRF AE and AG, a group O isolate, and a group N isolate. Assay sensitivity on this panel was 92%, with 89% correct subtype identification relative to sequence analysis. A linear relationship was found between the amount of input RNA in the reaction mixture and the time that the reaction became positive. The lower detection level of the assay was approximately 103 copies of HIV-1 RNA per reaction. In 38% of 50 serum samples from HIV-1-infected individuals with a detectable amount of virus, we could identify subtype sequences with a specificity of 94% by using sequencing and phylogenetic analysis as the “gold standard.” In conclusion, we showed the feasibility of the approach of using multiple molecular beacons labeled with different fluorophores in combination with isothermal amplification to identify and distinguish subtypes A, B, and C and CRFs AE and AG of HIV-1. Because of the low sensitivity, the assay in this format would not be suited for clinical use but can possibly be used for epidemiological monitoring as well as vaccine research studies.

[1]  S. Osmanov,et al.  Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization. , 1998, AIDS research and human retroviruses.

[2]  D. van Strijp,et al.  Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. , 1993, Journal of virological methods.

[3]  M. Salimans,et al.  Rapid and simple method for purification of nucleic acids , 1990, Journal of clinical microbiology.

[4]  E. De Clercq,et al.  Failure to quantify viral load with two of the three commercial methods in a pregnant woman harboring an HIV type 1 subtype G strain. , 1998, AIDS research and human retroviruses.

[5]  J Kolberg,et al.  A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. , 1997, Nucleic acids research.

[6]  D. van Strijp,et al.  NASBA isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection. , 1991, Journal of virological methods.

[7]  M. Peeters,et al.  V3 serotyping of HIV-1 infection: correlation with genotyping and limitations. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[8]  T. Quinn,et al.  Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. , 2000, The New England journal of medicine.

[9]  David E. Fisher,et al.  Background on Bruno , 2000, Science.

[10]  T. Kievits,et al.  Qualitative and quantitative detection of HIV‐1 RNA by nucleic acid sequence‐based amplification , 1993, AIDS.

[11]  C. Mathiot,et al.  Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. , 1996, AIDS research and human retroviruses.

[12]  J. Goudsmit,et al.  Lack of correlation between V3‐loop peptide enzyme immunoassay serologic subtyping and genetic sequencing , 1998, AIDS.

[13]  Yves Van de Peer,et al.  TREECON for Windows: a software package for the construction and drawing of evolutionary trees for the Microsoft Windows environment , 1994, Comput. Appl. Biosci..

[14]  M. V. van Dooren,et al.  Single Rapid Real-Time Monitored Isothermal RNA Amplification Assay for Quantification of Human Immunodeficiency Virus Type 1 Isolates from Groups M, N, and O , 2001, Journal of Clinical Microbiology.

[15]  D. van Strijp,et al.  A one-tube quantitative HIV-1 RNA NASBA nucleic acid amplification assay using electrochemiluminescent (ECL) labelled probes. , 1994, Journal of virological methods.

[16]  S. Coppens,et al.  Simplified Strategy for Detection of Recombinant Human Immunodeficiency Virus Type 1 Group M Isolates bygag/env Heteroduplex Mobility Assay , 2000, Journal of Virology.

[17]  L. Heyndrickx,et al.  Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. , 1997, Journal of virological methods.

[18]  S. Coppens,et al.  Simplified strategy for detection of recombinant human immunodeficiency virus type 1 group M isolates by gag/env heteroduplex mobility assay. Study Group on Heterogeneity of HIV Epidemics in African Cities. , 2000, Journal of virology.

[19]  J. Mascola,et al.  Development of Calibrated Viral Load Standards for Group M Subtypes of Human Immunodeficiency Virus Type 1 and Performance of an Improved AMPLICOR HIV-1 MONITOR Test with Isolates of Diverse Subtypes , 1999, Journal of Clinical Microbiology.

[20]  Fred Russell Kramer,et al.  Multicolor molecular beacons for allele discrimination , 1998, Nature Biotechnology.

[21]  F. Brun-Vézinet,et al.  Identification of a new human immunodeficiency virus type 1 distinct from group M and group O , 1998, Nature Medicine.

[22]  G. Learn,et al.  HIV-1 Nomenclature Proposal , 2000, Science.

[23]  I Spijkerman,et al.  AIDS prognosis based on HIV‐1 RNA, CD4+ T‐cell count and function: markers with reciprocal predictive value over time after seroconversion , 1997, AIDS.

[24]  Sanjay Tyagi,et al.  Multiplex detection of single-nucleotide variations using molecular beacons. , 1999, Genetic analysis : biomolecular engineering.

[25]  L. Kalish,et al.  Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group. , 1999, The New England journal of medicine.

[26]  D. van Strijp,et al.  The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? , 1994, Virology.

[27]  L. Heyndrickx,et al.  Isolation and partial characterization of an unusual human immunodeficiency retrovirus from two persons of west-central African origin , 1990, Journal of virology.

[28]  J. Goudsmit,et al.  Design and Evaluation of a Human Immunodeficiency Virus Type 1 RNA Assay Using Nucleic Acid Sequence-Based Amplification Technology Able To Quantify Both Group M and O Viruses by Using the Long Terminal Repeat as Target , 1999, Journal of Clinical Microbiology.

[29]  J. Albert,et al.  Subtype‐specific problems with quantification of plasma HIV‐1 RNA , 1997, AIDS.

[30]  J. Mellors,et al.  Quantitation of HIV-1 RNA in Plasma Predicts Outcome after Seroconversion , 1995, Annals of Internal Medicine.

[31]  D. van Strijp,et al.  NASBATM isothermal enzymatic in vitro nucleic acid amplification optimized for the diagnosis of HIV-1 infection , 1991 .

[32]  John W. Mellors,et al.  Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma , 1996, Science.

[33]  Sanjay Tyagi,et al.  Molecular Beacons: Probes that Fluoresce upon Hybridization , 1996, Nature Biotechnology.

[34]  D. R. Kuritzkes,et al.  HIV viral load markers in clinical practice , 1996, Nature Medicine.

[35]  K. Harada,et al.  Direct Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects , 1996, Science.

[36]  D. Mcclernon,et al.  Evaluation of a second-generation nucleic acid sequence-based amplification assay for quantification of HIV type 1 RNA and the use of ultrasensitive protocol adaptations. , 2000, AIDS research and human retroviruses.

[37]  Sanjay Tyagi,et al.  Multiplex detection of four pathogenic retroviruses using molecular beacons. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. G. Shpaer,et al.  Genetic relationships determined by a DNA heteroduplex mobility assay: analysis of HIV-1 env genes. , 1993, Science.

[39]  J. Goudsmit,et al.  Human immunodeficiency virus type 1 subtypes defined by env show high frequency of recombinant gag genes. The UNAIDS Network for HIV Isolation and Characterization , 1996, Journal of virology.

[40]  D. Richman,et al.  Isothermal, in vitro amplification of nucleic acids by a multienzyme reaction modeled after retroviral replication. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[41]  W. S. Clark,et al.  Clinical Comparison of an Enhanced-Sensitivity Branched-DNA Assay and Reverse Transcription-PCR for Quantitation of Human Immunodeficiency Virus Type 1 RNA in Plasma , 1998, Journal of Clinical Microbiology.

[42]  D. Hillyard,et al.  Evaluation of the Ultrasensitive Roche Amplicor HIV-1 Monitor Assay for Quantitation of Human Immunodeficiency Virus Type 1 RNA , 1999, Journal of Clinical Microbiology.

[43]  B. Korber,et al.  Evaluation of different V3 peptides in an enzyme immunoassay for specific HIV type 1 group O antibody detection. , 1998, AIDS research and human retroviruses.